SI-BONE, Inc. (SIBN) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-24

Business type: Asset play

How it makes money

It earns revenue by selling patented titanium implants and surgical instruments primarily through a direct sales force and third-party sales agents.

It markets a series of patented titanium implants and related instruments used for minimally invasive treatments in sacroiliac joint dysfunction, thoracolumbar fixation and fusion, and pelvic trauma. Revenue depends heavily on procedure volume and the ongoing adoption of its technology platforms by physicians.

Sales are conducted primarily through a direct sales force and third-party sales agents in the United States, and through a combination of a direct sales force, sales agents, and resellers internationally.

What protects it: the moat

It protects its market position through proprietary product designs, clinical evidence, and regulatory clearances, though major competitors pose a constant threat.

The company relies on its patented implant designs, ongoing research and development initiatives, and regulatory designations such as breakthrough device statuses granted by the FDA. Management notes that it operates in a highly sensitive field where competitors can introduce alternative products or procedures.

Management discloses that many competitors are major medical device companies with substantially greater financial, technical, and marketing resources, and some sell broad suites of products that can be bundled together for operating rooms.

What growth costs

It reinvests capital primarily into research and development initiatives and the expansion of its commercial infrastructure and surgical capacity.

The company invests in research and development to bring differentiated solutions to market and generate clinical evidence to drive adoption and reimbursement. In 2025, it spent $17.4 million on research and development, representing 9% of its 2025 revenue.

To support growth, it also invests significantly in its commercial infrastructure, sales force expansion, instrument trays, and implant inventory held ready for surgery.

What could damage it

Competitors offering bundled surgical systems could limit the compatibility or sales of its products, directly impairing its revenue growth.

Larger medical device competitors sell broad suites of products used together in operating rooms, such as surgical imaging, navigation, and robotic systems. If these competitors use technology, contracts, or intellectual property measures to limit or eliminate the compatibility of their systems with its implants, sales could decline or fail to grow.

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Other companies in Medical Devices